1. GPCR/G Protein
  2. Vasopressin Receptor
  3. Nelivaptan

Nelivaptan  (Synonyms: SSR-149415)

目录号: HY-10066 纯度: 99.89%
COA 产品使用指南 技术支持

Nelivaptan (SSR-149415) 是一种具有口服活性的选择性 vasopressin V1b Receptor 拮抗剂 (对天然和重组大鼠 V1b 受体的 Ki 值分别为 3.7 和 1.3 nM)。Nelivaptan 抑制精氨酸加压素 (AVP) 诱导的 Ca2+ 增加和促肾上腺皮质激素分泌。Nelivaptan 可用于压力、焦虑及抑郁症的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Nelivaptan

Nelivaptan Chemical Structure

CAS No. : 439687-69-1

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
1 mg ¥720
In-stock
5 mg ¥1480
In-stock
10 mg ¥2200
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 Vasopressin Receptor 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Nelivaptan (SSR-149415) is a selective and orally active vasopressin V1b receptor antagonist (Ki: 3.7 and 1.3 nM for native and recombinant rat V1b receptors, respectively). Nelivaptan inhibits arginine vasopressin (AVP)-induced Ca2+ increase and corticotropin secretion. Nelivaptan can be used for research of stress, anxiety and depression[1][2].

体外研究
(In Vitro)

Nelivaptan (0.1-100 nM,20 分钟) 在转染了人 V1b 受体的 CHO 细胞中有效抑制精氨酸加压素 (AVP) 诱导的 Ca2 增加[1]
Nelivaptan (0.9-15 nM,45 分钟) 在转染了人 V1b 受体的 CHO 细胞中以竞争性方式抑制 [3H]AVP 结合[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Nelivaptan (1-30 mg/kg;注射外源性 AVP 前 30 分钟腹腔注射或 2 小时口服) 可抑制 Sprague-Dawley 大鼠中外源性 AVP 诱导的血浆促皮质素增加[1]
Nelivaptan (1-10 mg/kg;口服;注射 AVP 前 1、2、3、4 和 6 小时) 在 Sprague-Dawley 大鼠中剂量依赖性抑制由外源性 AVP 加促肾上腺皮质激素释放因子刺激引起的促肾上腺皮质激素增加[1]
Nelivaptan (1-10 mg/kg;测试前 30 分钟或 60 分钟腹腔注射;或口服 7 天) 在雄性 NMRI 小鼠中,急性和 7 天重复给药后表现出抗焦虑样活性[1]
Nelivaptan (30 mg/kg;腹腔注射;每天给药,连续两周) 在慢性轻度应激的雄性 Wistar 大鼠中,即使在神经发生受阻的情况下,仍能有效降低抑郁样行为的测量指标 (习得性无助和快感缺乏) [2]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Wistar rats (300-400 g, aged 3 months) with chronic mild stress[2]
Dosage: 30 mg/kg
Administration: Intraperitoneal injection (i.p.); daily for two weeks
Result: Chronic administration reversed learned helplessness and anhedonia even when methylazoxymethanol (MAM) was administered.
Attenuated these depressive-like behaviors after 1 week.
Restored the density of Ki-67-positive cells to control levels.
Animal Model: Male Sprague-Dawley CD rats (275-300 g)[1]
Dosage: 1, 3, 10, 30 mg/kg
Administration: Intraperitoneal injection (i.p.) or Oral gavage (p.o.); 30 min i.p. or 2 h p.o. before an exogenous AVP injection
Result: Antagonized AVP-induced corticotropin secretion in a dose-dependent manner by both intraperitoneal and oral routes.
The inhibition was significant from 10 mg/kg p.o. and 3 mg/kg i.p. upwards.
The inhibitory action lasted significantly for more than 2 h at 10 mg/kg i.p. and up to 4 h at 10 mg/kg p.o..
Had no effect on basal corticotropin plasma levels up to 30 mg/kg p.o..
Animal Model: Male Sprague-Dawley CD rats (275-300 g)[1]
Dosage: 1, 3, 10 mg/kg
Administration: Oral gavage (p.o.); 1, 2, 3, 4, and 6 h before the AVP challenge (10 mg/kg)
Result: Produced powerful dose-dependent inhibition of the corticotropin increase in response to exogenous AVP plus corticoliberin; the effect was significant from the dose of 3 mg/kg p.o.. Complete blockade was achieved at 10 mg/kg.
Showed a fast onset of action, the inhibitory effect was maximal at 1 h after administration.
The inhibitory effect on corticotropin secretion lasted significantly more than 4 h, demonstrating a long-lasting oral effect in a specific V1b-related model.
Animal Model: Male NMRI mice (20 g)[1]
Dosage: 1, 3, 10 mg/kg
Administration: Intraperitoneal injection (i.p.) or Oral gavage (p.o.); i.p. (1, 3, 10 mg/kg) 30 min or 60 min befeore; p.o. (10 mg/kg) for 7 days,
Result: In the acute experiments, i.p. and p.o. compound increased the number of punished crossings showing marked anxiolytic effects.
Post hoc analysis revealed that these effects reached statistical significance from 3 mg/kg p.o. and i.p.
The anxiolytic-like activity was still significantly maintained when given repeatedly at 10 mg/kg p.o. for 7 days.
The oral time course of the anxiolytic-like action performed at 10 mg/kg indicated that effects lasted for more than 4 h.
Clinical Trial
分子量

630.11

Formula

C30H32ClN3O8S

CAS 号
性状

固体

颜色

White to off-white

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据
细胞实验: 

DMSO 中的溶解度 : 2 mg/mL (3.17 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.5870 mL 7.9351 mL 15.8702 mL
5 mM --- --- ---
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
计算结果
工作液所需浓度 : mg/mL
纯度 & 产品资料

纯度: 99.89%

参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.5870 mL 7.9351 mL 15.8702 mL 39.6756 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Nelivaptan
目录号:
HY-10066
需求量: